Time course I | % | | GABAAreceptor agonist treatments | % |
1-Day PB | 52.51-a
| 3 | PB 500 μM | 38.81-a
| 2 |
2-Day PB | 41.0a,d
| 3.3 | Ethanol 100 mM | 101.2 | 3.3 |
3-Day PB | 38.7a,c
| 3.8 | (+) HX 500 μM | 82.21-a
| 2.4 |
Time course II | | | (−) HX 500 μM | 69.61-a
| 2.4 |
1-Day PB | 91.5 | 5 | Allopregnanolone1-f 1 μM | 100.7 | 3 |
2-Day PB | 60.5a,c
| 4.6 | Allopregnanolone1-f2 μM | 95.51-b
| 1.4 |
3-Day PB | 38.61-a
,
1-c
,
1-e
| 2 |
Time course III | | | GABAA receptor blockade for 3 days |
1-Day PB | 46.51-a
| 2.8 | PX 10 μM | 95.1 | 2.2 |
2-Day PB | 38.91-a
| 1.9 | PX 10 μM and PB 500 μM | 20.2a,c
| 2.7 |
3-Day PB | 28.4a,c,e
| 1.4 | PB 500 μM | 23.3a,c
| 2.2 |
PB dose-response | | GABAA receptor blockade for 1 day |
100 μM PB | 84.31-a
| 3.2 | PX 10 μM | 102.9 | 18 |
250 μM PB | 61.1a,c
| 2.4 | PX 10 μM and PB 500 μM | 34.3a,d
| 4.5 |
500 μM PB | 45.4a,c,e
| 2.8 | PB 500 μM | 42.9a,d
| 2.4 |